1. Home
  2. INMD

as of 03-11-2026 12:27pm EST

$13.10
$0.17
-1.28%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Founded: 2008 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 842.0M IPO Year: 2018
Target Price: $16.75 AVG Volume (30 days): 870.5K
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $12.95 - $19.09 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 1.7% Revenue Growth (next year): 3.99%
P/E Ratio: 10.11 Index: N/A
Free Cash Flow: N/A FCF Growth: -36.15%

Share on Social Networks: